Reuters logo
10 months ago
BRIEF-Staidson Beijing BioPharmaceuticals sees 2016 Q1 to Q3 net profit up 10 pct to 30 pct
October 13, 2016 / 9:21 AM / 10 months ago

BRIEF-Staidson Beijing BioPharmaceuticals sees 2016 Q1 to Q3 net profit up 10 pct to 30 pct

Oct 13 (Reuters) - Staidson Beijing BioPharmaceuticals Co Ltd

* Sees net profit for 2016 Q1 to Q3 to increase by 10 percent to 30 percent, or to be about 190.4 million yuan to 225 million yuan

* Says the net profit of 2015 Q1 to Q3 was 173.1 million yuan

* Comments that increased sales efficiency and increased sales of main products are the main reasons for the forecast

Source text in Chinese: goo.gl/HMKxch

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below